News & Events

In this section

Instem's SEND Solution Showcasing at Japanese Society of Toxicology Meeting

Instem and Partner CTCLS to Co-exhibit at the 41st Annual Meeting of the JSOT; Kobe, Japan.

CONSHOHOCKEN, PA - - July 2, 2014 - - Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it will be co-exhibiting with partner, CTCLS at the Japanese Society of Toxicology (JSOT) Annual meeting July 2nd – 4th in Kobe, Japan.

Following the release of the US Food and Drug Administration’s draft guidance for electronic submissions earlier this year, Instem’s presence at JSOT will focus on helping organizations learn more about CDISC’s Standard for Exchange of Nonclinical Data (SEND) and how both sponsors and CRO’s can prepare for and leverage the standard with industry leading software tools.

JSOT delegates will be able to learn about SEND and view demonstrations ofInstem’s market-leading submit™ software solution suite, which enables organizations to convert data from any source system into SEND files while allowing sponsors, CRO’s and regulators to share, visualize and analyze study data more efficiently.

Neil Donaldson, Instem’s Vice President of Sales, Europe and Asia, commented, “I am pleased to be joining CTCLS at JSOT to reinforce Instem’s commitment to SEND and help our industry colleagues in Japan further embrace the standard. We have seen an increase in the global demand for our SEND solutions and services in 2014 and our presence at this meeting supports Instem’s role as the leading provider.”

Attendees may visit Instem and CTCLS at booth #34 at JSOT, July 2-4th at the Kobe Convention Center. Also featured at the booth will be Instem’s market-leading Provantis®  software solution, the fully integrated system for organizations and universities engaged in non-clinical evaluation studies.

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600

Gary Mitchell (US HQ)
Tel: 610-941-0990